Xillix Ltd. (Subsidiary of Xillix Technologies) (Richmond, BC)

CMDF Investment: $5,000,000.00
Focus: Cancer   Other  
www.xillix.com

Xillix is a leader in the research; development and commercialization of proprietary medical imaging technology; based on tissue fluorescence; a technique that substantially improves upon the clinician's ability to detect the early presence and localization of cancerous lesions. Their lead product is the LIFE-Lung system is the company's lead product for lung cancer detection; and is approved for sale in the U.S.; Canada; Europe and Japan. In clinical studies of Xillix's first generation lung device; the U.S. Food and Drug Administration confirmed that the company's device improved the physician's ability to detect lung cancer by 171% compared with conventional white light bronchoscopy alone.